Patents by Inventor Kurtis E. Bachman

Kurtis E. Bachman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240139265
    Abstract: The disclosure relates to prostate neoantigens, polynucleotides encoding them, vectors, host cells, recombinant virus particles, vaccines comprising the neoantigens, proteinaceous molecules binding the prostate neoantigens, and methods of making and using them.
    Type: Application
    Filed: June 27, 2023
    Publication date: May 2, 2024
    Inventors: Kurtis E. Bachman, Vipul Bhargava, Darryl L. Davis, Vinod Krishna, Guido Leoni, David Pocalyko, Pegah Safabakhsh, Manuel Sepulveda, Derick Siegel, Marco Gottardis
  • Patent number: 11793843
    Abstract: The disclosure relates to prostate neoantigens, polynucleotides encoding them, vectors, host cells, recombinant virus particles, vaccines comprising the neoantigens, proteinaceous molecules binding the prostate neoantigens, and methods of making and using them.
    Type: Grant
    Filed: January 9, 2020
    Date of Patent: October 24, 2023
    Assignee: Janssen Biotech, Inc.
    Inventors: Kurtis E. Bachman, Vipul Bhargava, Darryl L. Davis, Vinod Krishna, Guido Leoni, David Pocalyko, Pegah Safabakhsh, Manuel Sepulveda, Derick Siegel, Marco Gottardis
  • Publication number: 20220288041
    Abstract: Disclosed herein are JAK inhibitors that have low systemic toxicity. In some aspects, the disclosure includes methods for treating disease states, disorders, and conditions mediated by JAK, such as stomacho-intestinal system cancers, including colorectal cancers and familial adenomatous polyposis.
    Type: Application
    Filed: March 9, 2022
    Publication date: September 15, 2022
    Inventors: Edward F. Attiyeh, Kurtis E. Bachman, Gerald C. Chu, Tatiana Koudriakova, David C. Polidori, Gary V. Borzillo
  • Publication number: 20200222478
    Abstract: The disclosure relates to prostate neoantigens, polynucleotides encoding them, vectors, host cells, recombinant virus particles, vaccines comprising the neoantigens, proteinaceous molecules binding the prostate neoantigens, and methods of making and using them.
    Type: Application
    Filed: January 9, 2020
    Publication date: July 16, 2020
    Inventors: Kurtis E. Bachman, Vipul Bhargava, Darryl L. Davis, Vinod Krishna, Guido Leoni, David Pocalyko, Pegah Safabakhsh, Manuel Sepulveda, Derick Siegel, Marco Gottardis
  • Publication number: 20100048523
    Abstract: A composition and method of using are provided, which composition includes: at least one compound selected from the group including a compound having formula (I), a salt thereof, a prodrug thereof, a compound having formula (II), a salt thereof, a prodrug thereof, and a combination thereof, the compounds being described herein, and a combination thereof, and at least one pharmaceutically acceptable carrier; wherein the composition is suitable for administration to a mammal. Methods of using the compound are also provided.
    Type: Application
    Filed: April 6, 2007
    Publication date: February 25, 2010
    Inventors: Kurtis E. Bachman, Ben Ho Park